Titlebook: Novel therapeutic approaches for gastrointestinal malignancies; Ganji Purnachandra Nagaraju,Sujatha Peela Book 2020 The Editor(s) (if appl

Platelet

Astigmatism

Small Molecule-Targeted Therapies for GI Cancers: Success and Failures,nclude surgical resection, radiation therapy, and chemotherapy. These treatment regimens can be employed individually or in combinations. The heterogeneity in gastrointestinal (GI) cancers and development of resistance to chemotherapeutics agents and the secondary complication due to their toxic act

Keratin

Epigenetic Biomarkers for the Detection of Gastrointestinal Cancers, sexes. Despite considerable progress in the therapy of gastrointestinal cancers with an overall improvement in the survival rates, the incidence of both gastric and colorectal cancers is on the rise globally. This emphasizes the need to identify novel potential biomarkers that could be of immense h

Mediocre

CD151: A Lateral Organizer and Modulator of Tumor Microenvironment in Gastrointestinal Cancers,year survival rate and high mortality rate due to extremely high metastatic ability. Even though GI tract cancers differ in histology, they share primary events of metastasis and master regulators of tumor microenvironment (TME), which initiate differentiation programs during ontogeny and tumor prog

新手

Identification of Potential Key Genes Involved in Progression of Gastric Cancer Using Bioinformatice of cancer mortality in the world. Detection of key genes involved in gastric cancer progression and prognosis leads to efficient approach to treat cancer.. Two datasets (PRJNA506381 and PRJNA438844) from Sequence Read Archive (SRA) database were analysed using available bioinformatics tools and di